|
GEM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.550400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.814600E-01 |
| Normal-vs-Stage2 |
9.339400E-01 |
| Normal-vs-Stage3 |
3.705000E-01 |
| Normal-vs-Stage4 |
8.361200E-01 |
| Stage1-vs-Stage2 |
9.933000E-01 |
| Stage1-vs-Stage3 |
2.500800E-01 |
| Stage1-vs-Stage4 |
5.801200E-01 |
| Stage2-vs-Stage3 |
5.387400E-01 |
| Stage2-vs-Stage4 |
7.963400E-01 |
| Stage3-vs-Stage4 |
1.386800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.394600E-01 |
| Normal-vs-AfricanAmerican |
8.256200E-01 |
| Normal-vs-Asian |
8.391400E-01 |
| Caucasian-vs-AfricanAmerican |
9.960200E-01 |
| Caucasian-vs-Asian |
9.067800E-01 |
| AfricanAmerican-vs-Asian |
9.080000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.493200E-01 |
| Normal-vs-Female |
3.151600E-01 |
| Male-vs-Female |
5.122200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.773400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.760800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.948600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.790600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.281900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.987000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.103200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.198420E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.421800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.250600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.565410E-01 |
| Normal-vs-Grade 2 |
5.243800E-01 |
| Normal-vs-Grade 3 |
5.522800E-01 |
| Normal-vs-Grade 4 |
3.537200E-01 |
| Grade 1-vs-Grade 2 |
2.438000E-01 |
| Grade 1-vs-Grade 3 |
9.456000E-02 |
| Grade 1-vs-Grade 4 |
2.598200E-01 |
| Grade 2-vs-Grade 3 |
4.342000E-02 |
| Grade 2-vs-Grade 4 |
6.587600E-01 |
| Grade 3-vs-Grade 4 |
3.962100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.401800E-01 |
| Normal-vs-ccB subtype |
1.454410E-01 |
| ccA subtype-vs-ccB subtype |
2.177400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.463400E-01 |
| Normal-vs-N1 |
8.833800E-02 |
| N0-vs-N1 |
6.316700E-03 |
|
|
